| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 96, 423-438, Copyright © 1979 by American Society for Investigative Pathology
REGULAR ARTICLES |
JM Gerrard, SE Kindom, DA Peterson, J Peller, KE Krantz and JG White
Decanoyl-, palmitoyl-, and oleoyl-lysophosphatidic acid (LPA) were studied for their effects on platelet aggregation and intracellular calcium flux. Palmitoyl-LPA and oleoyl-LPA both caused a concentration- dependent aggregation of human blood platelets at concentrations of 12-- 300 microM. Aggregation by adenosine diphosphate (ADP) was enhanced at slightly lower concentrations. First-wave aggregation induced by these LPAs was not blocked by aspirin, indomethacin, or heparin, suggesting similarities to ADP aggregation. However, in washed platelets with a high calcium concentration, no serotonin secretion was observed, even though full aggregation occurred, suggesting that aggregation was not due to released ADP. This concept was supported by studies of platelets deficient in the storage pool of ADP and serotonin, which had a normal first-wave aggregation response to palmitoyl-LPA. Aggregation induced by palmitoyl LPA was inhibited by prostaglandin E1 (PGE1), theophylline, and ethylenediaminotetraacetate (EDTA), though in the presence of EDTA shape change occurred. Aggregation stimulated by palmitoyl-LPA or oleoyl-LPA was characterized by changes in the shape of the platelets with development of pseudopods and centralization of granules closely surrounded by contractile microfilaments and supporting microtubules. The addition of palmitoyl-LPA and oleoyl-LPA, but not decanoyl-LPA, caused the release of calcium from a platelet membrane fraction that contains elements of the intracellular calcium storage system and actively concentrates this cation in the presence of adenosine triphosphate (ATP) and magnesium. It is suggested that LPAs cause aggregation by stimulating the release of calcium intracellularly.
This article has been cited by other articles:
 |
|
 |
|
  X. Ye Lysophospholipid signaling in the function and pathology of the reproductive system Hum. Reprod. Update, September 1, 2008; 14(5): 519 - 536. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Gustin, E. Delaive, M. Dieu, D. Calay, and M. Raes Upregulation of Pentraxin-3 in Human Endothelial Cells After Lysophosphatidic Acid Exposure Arterioscler. Thromb. Vasc. Biol., March 1, 2008; 28(3): 491 - 497. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Pamuklar, J. S. Lee, H.-Y. Cheng, M. Panchatcharam, S. Steinhubl, A. J. Morris, R. Charnigo, and S. S. Smyth Individual Heterogeneity in Platelet Response to Lysophosphatidic Acid: Evidence for a Novel Inhibitory Pathway Arterioscler. Thromb. Vasc. Biol., March 1, 2008; 28(3): 555 - 561. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Flaumenhaft, J. R. Dilks, N. Rozenvayn, R. A. Monahan-Earley, D. Feng, and A. M. Dvorak The actin cytoskeleton differentially regulates platelet {alpha}-granule and dense-granule secretion Blood, May 15, 2005; 105(10): 3879 - 3887. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Tanaka, H. Tsutsui, K. Hirano, T. Koike, A. Tokumura, and K. Satouchi Quantitative analysis of lysophosphatidic acid by time-of-flight mass spectrometry using a phosphate-capture molecule J. Lipid Res., November 1, 2004; 45(11): 2145 - 2150. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D.-S. Im Discovery of new G protein-coupled receptors for lipid mediators J. Lipid Res., March 1, 2004; 45(3): 410 - 418. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Hasegawa, J. R. Erickson, G. J. Goddard, S. Yu, S. Liu, K. W. Cheng, A. Eder, K. Bandoh, J. Aoki, R. Jarosz, et al. Identification of a Phosphothionate Analogue of Lysophosphatidic Acid (LPA) as a Selective Agonist of the LPA3 Receptor J. Biol. Chem., March 28, 2003; 278(14): 11962 - 11969. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Sugiura, S. Nakane, S. Kishimoto, K. Waku, Y. Yoshioka, and A. Tokumura Lysophosphatidic acid, a growth factor-like lipid, in the saliva J. Lipid Res., December 1, 2002; 43(12): 2049 - 2055. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-J. Xu, S. S. Rathi, M. Zhang, P. Bhugra, and N. S. Dhalla Mechanism of the Positive Inotropic Effect of Lysophosphatidic Acid in Rat Heart Journal of Cardiovascular Pharmacology and Therapeutics, June 1, 2002; 7(2): 109 - 115. [Abstract] [PDF]
|
|
|
|
|
|
A. Tokumura, Y. Kanaya, M. Kitahara, M. Miyake, Y. Yoshioka, and K. Fukuzawa Increased formation of lysophosphatidic acids by lysophospholipase D in serum of hypercholesterolemic rabbits J. Lipid Res., February 1, 2002; 43(2): 307 - 315. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
